NCT06303492

Brief Summary

Pulmonary aspiration of gastric contents is a serious patient safety problem accounting for 50% of anesthesia-related mortality. The risk is higher in patients undergoing emergency surgery as the gastric content is uncertain which poses a challenge to anesthetic decision-making. Standard clinical assessment to identify at-risk patients primarily relies on preoperative fasting guidelines and is not adequate for patients undergoing emergency surgeries. Point-of-care gastric ultrasound (GUS) has emerged as an accurate bedside tool providing information regarding the type and volume of gastric contents. When GUS was added to standard clinical assessment, anesthetic management plan changed in 71% of adult elective and 37% of pediatric emergency surgical procedures. Such data is lacking in adult patients undergoing emergency surgeries. The investigators propose a multicentre mixed-method study to evaluate the impact of GUS on aspiration risk assessment and subsequent Anesthetic Plan before emergency surgeries. The evidence from this study will improve patient safety by accurately identifying patients at risk of aspiration and tailoring anesthetic techniques and airway management to prevent pulmonary aspiration in patients undergoing emergency surgeries.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
142

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2024

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 28, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 12, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

March 12, 2024

Status Verified

February 1, 2024

Enrollment Period

1.6 years

First QC Date

February 28, 2024

Last Update Submit

March 6, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Proportion of change in Anesthetic Plan

    The primary outcome of the study is a change from the initial anesthetic plan after viewing GUS results in the intervention group, and after being given the opportunity to revise the plan in the control group.

    Baseline

Secondary Outcomes (1)

  • Percentage change in the three-category risk assessment before and after GUS

    Baseline

Study Arms (2)

Gastric ultrasound (GUS) group

EXPERIMENTAL

Aspiration risk assessment using GUS in addition to the standard clinical assessment.

Procedure: GUS

Control

NO INTERVENTION

Aspiration risk assessment only by standard clinical assessment, and no GUS

Interventions

GUSPROCEDURE

Aspiration risk assessment by GUS

Gastric ultrasound (GUS) group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>18 years
  • American Society of Anesthesiologists' (ASA) physical status I-III
  • Patients scheduled for non-elective non-cardiac surgery.

You may not qualify if:

  • Abnormal anatomy of the upper gastro-intestinal tract (including hiatus hernia, gastric tumors, and previous surgeries of the upper gastrointestinal tract).
  • Extrinsic gastric compression obtained from the medical history or during the actual ultrasound examination.
  • Pregnancy.
  • Attending anesthesiologist refusal to include the patient for participation in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Cristian Arzola, MD, MSc

CONTACT

Jonathan Sy

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 28, 2024

First Posted

March 12, 2024

Study Start

May 1, 2024

Primary Completion

December 1, 2025

Study Completion

April 1, 2026

Last Updated

March 12, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share